Comparison between Glenmark Life Sciences IPO and Paytm IPO.
Glenmark Life Sciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Paytm IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Paytm IPO is up to ₹18,300.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Paytm IPO is ₹2,150.00 per share.
| Glenmark Life Sciences IPO | Paytm IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹695.00 per share | ₹2,080.00 per share |
| Issue Price (Upper) | ₹720.00 per share | ₹2,150.00 per share |
| Issue Price (Final) | ₹720.00 per share | ₹2,150.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 20 shares | 6 shares |
| Fresh Issue Size | 1,47,22,222 shares | 3,86,04,651 shares |
| Fresh Issue Size (Amount) | up to ₹1,060.00 Cr | up to ₹8,300.00 Cr |
| OFS Issue Size | 63,00,000 shares | 4,65,11,627 shares |
| OFS Issue Size (Amount) | up to ₹453.60 Cr | up to ₹10,000.00 Cr |
| Issue Size Total | 2,10,22,222 shares | 8,51,16,278 shares |
| Issue Size Total (Amount) | up to ₹1,513.60 Cr | up to ₹18,300.00 Cr |
Glenmark Life Sciences IPO opens on Jul 27, 2021, while Paytm IPO opens on Nov 08, 2021. The closing date of Glenmark Life Sciences IPO and Paytm IPO is Jul 29, 2021, and Nov 10, 2021, respectively.
| Glenmark Life Sciences IPO | Paytm IPO | |
|---|---|---|
| Anchor Bid Date | Jul 26, 2021 | Nov 03, 2021 |
| Issue Open | Jul 27, 2021 | Nov 08, 2021 |
| Issue Close | Jul 29, 2021 | Nov 10, 2021 |
| Basis Of Allotment (Tentative) | Aug 03, 2021 | Nov 15, 2021 |
| Initiation of Refunds (Tentative) | Aug 04, 2021 | Nov 16, 2021 |
| Credit of Share (Tentative) | Aug 05, 2021 | Nov 17, 2021 |
| Listing date (Tentative) | Aug 06, 2021 | Nov 18, 2021 |
| Anchor Lockin End date 1 | Sep 02, 2021 | Dec 15, 2021 |
| Anchor Lockin End date 2 | Nov 01, 2021 | Feb 13, 2022 |
Glenmark Life Sciences IPO P/E ratio is , as compared to Paytm IPO P/E ratio of .
| Glenmark Life Sciences IPO | Paytm IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | |||||
| Promoter Shareholding (Post-Issue) | 82.84 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹8821.96 Cr. | ₹139378.84 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Glenmark Life Sciences IPO Retail Individual Investors (RII) are offered 73,57,778 shares while in Paytm IPO retail investors are offered 73,57,778 shares. Qualified Institutional Buyers (QIB) are offered 42,04,450 shares in Glenmark Life Sciences IPO and 2,55,34,884 shares in Paytm IPO.
| Glenmark Life Sciences IPO | Paytm IPO | |
|---|---|---|
| Anchor Investor Reservation | 63,06,660 shares | 3,83,02,326 shares |
| Market Maker Reservation | ||
| QIB | 42,04,450 shares | 2,55,34,884 shares |
| NII | 31,53,334 shares | 1,27,67,441 shares |
| RII | 73,57,778 shares | 85,11,627 shares |
| Employee | ||
| Others | ||
| Total | 2,10,22,222 shares | 8,51,16,278 shares |
Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Paytm IPO subscribed 1.89x.
| Glenmark Life Sciences IPO | Paytm IPO | |
|---|---|---|
| QIB (times) | 36.97x | 2.79x |
| NII (times) | 122.54x | 0.24x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 14.63x | 1.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 44.17x | 1.89x |
